Table 1. Correlation between GRSF1 levels and clinicopathologic features in LUAD.
| Characteristics | LUAD (n=479) | χ2 | P value | |
|---|---|---|---|---|
| GRSF1 low (n=341) | GRSF1 high (n=138) | |||
| Age (years) | 0.196 | 0.658 | ||
| ≥60 | 246 | 103 | ||
| <60 | 95 | 35 | ||
| Gender | 6.873 | 0.009* | ||
| Male | 146 | 78 | ||
| Female | 195 | 60 | ||
| Nodes_pathologic_pN | 0.596 | |||
| N0 | 229 | 87 | ||
| N1 | 64 | 27 | ||
| N2 | 46 | 24 | ||
| N3 | 2 | 0 | ||
| Tumor_pathologic_pT | 13.62 | 0.003* | ||
| T1 | 131 | 33 | ||
| T2 | 175 | 78 | ||
| T3 | 26 | 18 | ||
| T3 | 9 | 9 | ||
| Pathologic_tumor_stage | 3.775 | 0.287 | ||
| I | 193 | 65 | ||
| II | 81 | 38 | ||
| III | 53 | 27 | ||
| IV | 14 | 8 | ||
*, statistically significant P values, P<0.05. GRSF1, guanine-rich RNA sequence binding factor 1; LUAD, lung adenocarcinoma.